Should Pfizer's Strong Quarter Calm Investor Concerns About the Stock?

Can this struggling stock turn things around?Demand for COVID-19 vaccines and drugs has been fading for a while now. And that has put a big dent in Pfizer's (PFE -1.60%) sales and profit numbers. On top of that, the stock is also facing headwinds due to losses in exclusivity for multiple drugs, which threaten to wipe off billions of dollars in revenue from its top line this decade.Recently, however, Pfizer reported some encouraging quarterly numbers. Also, the growth rate of many drugs was in double digits. ...